Literature DB >> 20408970

Epidemiology of allergic reactions to hymenoptera stings in Irish school children.

Aisling Jennings1, Eileen Duggan, Ivan J Perry, Jonathan O'B Hourihane.   

Abstract

The aim of this was to study generate the first epidemiological data regarding the prevalence of hymenoptera allergy among school children in Ireland. Questionnaires, including six sting-specific questions (1), were distributed to the parents of primary school children aged 6-8 and 11-13, divided equally between rural and urban backgrounds. From 110 schools, 4112 questionnaires were returned. A total of 1544 (37.5%) children had been stung in their lifetime. Among the total, 5.8% of children stung experienced a large local reaction, 3.4% had a mild (cutaneous) systemic reaction (MSR) and 0.8% experienced a moderate/severe systemic reaction (SSR); these figures respectively represent 2.2%, 1.3% and 0.2% of the total study group. On logistic regression analysis, older children and rural children were at a higher risk of being stung (OR 1.7; 95% CI 1.4-2.; OR 1.6; 95% CI 1.4-1.8 respectively). Rural dwellers and asthma sufferers were more likely to experience an SSR (OR 4.3; 95% CI 1.4-13.5 and OR 2.8; 95% CI 1.8-4.3, respectively). Hymenoptera stings are more common in rural than urban dwelling Irish children. Asthma imparted a greater risk of SSR in this study population. Severe reactions are unusual overall, occurring in <1% of those stung, a lower prevalence than in Israeli teenagers but in keeping with other European reports relating to young children.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20408970     DOI: 10.1111/j.1399-3038.2010.01054.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  9 in total

1.  Bee- and Wasp-Venom Sensitization in Schoolchildren of High- and Low-Socioeconomic Status Living in an Urban Area of Indonesia.

Authors:  Aldian I Amaruddin; Jan Pieter R Koopman; Munawir Muhammad; Serge A Versteeg; Sitti Wahyuni; Ronald van Ree; Maria Yazdanbakhsh; Firdaus Hamid; Erliyani Sartono
Journal:  Int Arch Allergy Immunol       Date:  2021-05-05       Impact factor: 2.749

2.  Prevalence and characteristics of Hymenoptera venom allergy in urban school children aged 6 to 18 years living in Trabzon

Authors:  Özge Öziş Baba; Gülay Kaya; Mehtap Haktanır Abul; Neşe Kaklıkkaya; Murat Çakır; Fazıl Orhan
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

Review 3.  Facing Hymenoptera Venom Allergy: From Natural to Recombinant Allergens.

Authors:  Amilcar Perez-Riverol; Débora Lais Justo-Jacomini; Ricardo de Lima Zollner; Márcia Regina Brochetto-Braga
Journal:  Toxins (Basel)       Date:  2015-07-09       Impact factor: 4.546

4.  Safety and efficacy of venom immunotherapy: a real life study.

Authors:  Agnieszka Kołaczek; Dawid Skorupa; Monika Antczak-Marczak; Piotr Kuna; Maciej Kupczyk
Journal:  Postepy Dermatol Alergol       Date:  2017-04-13       Impact factor: 1.837

5.  Safety of 100 µg venom immunotherapy rush protocols in children compared to adults.

Authors:  Johanna Stoevesandt; Christine Hosp; Andreas Kerstan; Axel Trautmann
Journal:  Allergy Asthma Clin Immunol       Date:  2017-07-12       Impact factor: 3.406

Review 6.  Clinical Utility of Rush Venom Immunotherapy: Current Status.

Authors:  Vianney Gruzelle; Claire Mailhol; David W Waters; Laurent Guilleminault
Journal:  J Asthma Allergy       Date:  2020-01-07

Review 7.  Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?

Authors:  Umit Murat Sahiner; Stephen R Durham
Journal:  Front Immunol       Date:  2019-08-21       Impact factor: 7.561

Review 8.  Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes.

Authors:  Simon Blank; Johannes Grosch; Markus Ollert; Maria Beatrice Bilò
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

9.  Component-Resolved Evaluation of the Risk and Success of Immunotherapy in Bee Venom Allergic Patients.

Authors:  Marta Rosiek-Biegus; Robert Pawłowicz; Agnieszka Kopeć; Magdalena Kosińska; Marta Wrześniak; Marita Nittner-Marszalska
Journal:  J Clin Med       Date:  2022-03-17       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.